Urine profile linked to future cancer risk in healthy adults
Five-year cancer risk ranged from 0.18% in the lowest urine-score group to 32% in the highest.Five-year cancer risk ranged from 0.18% in the lowest urine-score group to 32% in the highest.
There are 8 papers on incident cancer in aging research: 8 observational studies in people. The newest story, Nov 6, 2026: “Urine profile linked to future cancer risk in healthy adults”.
8 papers study it163 more mention it11 findings
19 new papers in 30 daysSee all 171 papers on incident cancer
“0.795 (95% CI 0.789–0.801) for the all types of cancer outcome”
GAGome score
upin humans1HR 1.66
GAGome score predicts incident cancer in humans (Healthy asymptomatic adults) (HR 1.66, 95% CI 1.60–1.73 per standard deviation increase).
“A standard deviation increase in the GAGome score was associated with a significantly elevated risk of incident cancer”
HumansHealthy asymptomatic adultsPer standard deviation increase in GAGome scoreFive yearsn = 5,436
Urine profile linked to future cancer risk in healthy adults
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Regularly distributed physical activity
downin humans1HR 0.78
Regularly distributed physical activity is associated with incident cancer in humans (Individuals with CHIP; compared with inactive participants) (HR 0.78, 95% CI 0.58–1.05; not statistically significant).
“the association for active regular participants was not statistically significant (HR = 0.78, 95% CI: 0.58–1.05)”
HumansIndividuals with CHIP; compared with inactive participants≥150 min/week but not meeting WW criteria
Frontiers in oncology
Weekend warrior physical activity
downin humans1HR 0.67
Weekend warrior physical activity is associated with incident cancer in humans (Individuals with CHIP; compared with inactive participants) (HR 0.67, 95% CI 0.52–0.86).
“the active WW pattern was associated with a reduced cancer hazard (HR = 0.67, 95% CI: 0.52–0.86)”
HumansIndividuals with CHIP; compared with inactive participants≥150 min/week with ≥50% accumulated in 1–2 days
Frontiers in oncology
Moderate-to-vigorous physical activity
downin humans1HR 0.71
Moderate-to-vigorous physical activity is associated with incident cancer in humans (Individuals with CHIP; compared with inactive participants) (HR 0.71, 95% CI 0.56–0.89).
“Compared to inactive participants, active individuals exhibited a significantly lower hazard of overall cancer”
HumansIndividuals with CHIP; compared with inactive participants≥150 min/week
Frontiers in oncology
HbA1c
upin humans1
HbA1c is associated with incident cancer in humans (Concurrent heart failure and type 2 diabetes mellitus; HbA1c <5.0% versus 5.0–6.9%) (aHR 1.28, 95% CI 1.15–1.43).
“for incident cancer were 1.28 (1.15–1.43) for HbA1c <5.0%, 1.19 (1.08–1.31) for HbA1c 7.0–8.9%, and 1.37 (1.23–1.53) for HbA1c ≥9.0%”
HumansConcurrent heart failure and type 2 diabetes mellitus; HbA1c <5.0% versus 5.0–6.9%Median follow-up of 4.8 years58.4% malesn = 62,845
Blood sugar marker tied to cancer in heart failure and type 2 diabetes
ESC Congress 2026 abstract
XGBoost model
upin humans1
XGBoost model predicts incident cancer in humans (heart failure; internal held-out test sets) (AUROC 0.795, 95% CI 0.789–0.801).
“0.795 (95% CI 0.789–0.801) for the all types of cancer outcome”
Humansheart failure; internal held-out test sets
ESC Congress 2026 abstract
C-reactive protein
upin humans1
C-reactive protein is associated with incident cancer in humans (Excluding nonmelanoma skin cancers; free of cancer and cardiovascular disease at baseline).
“Whereas NT-proBNP, UAE, and hsCRP were significantly associated with incident CVD, only hsCRP was significantly associated with incident cancer.”
HumansExcluding nonmelanoma skin cancers; free of cancer and cardiovascular disease at baseline12 yearsn = 7,755
ESC Congress 2026 abstract
Plasma proteins
mixedin humans1
Plasma proteins are associated with incident cancer in humans (CKD; no prior cancer) (12 proteins significant after false discovery rate correction).
“Plasma proteomics identified 12 proteins associated with future cancer in CKD.”
HumansCKD; no prior cancerplasmaMedian 5.5 years45% femalesn = 2,975
Plasma Proteomics of Cancer Risk Among Patients with CKD
Kidney360
Antimony
upin humans1OR 1.72
Antimony is associated with incident cancer in humans (Single-metal model; not significant after FDR correction (p = 0.133)) (OR 1.72, 95% CI 1.13–2.63 per interquartile-range increase; FDR-adjusted p = 0.133).
“Single-metal models showed higher cancer odds with nickel (OR 1.63, 95% CI 1.08-2.45) and antimony (OR 1.72, 95% CI 1.13-2.63) per interquartile-range increase;”
HumansSingle-metal model; not significant after FDR correction (p = 0.133)hairPer interquartile-range increase3 yearsn = 2,120
Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
Nickel
upin humans1OR 1.6
Nickel is associated with incident cancer in humans (Mutually adjusted metal model in adults in Mexico) (OR 1.60, 95% CI 1.03–2.56).
“after mutual adjustment, only nickel remained associated with cancer (OR 1.60, 95% CI 1.03-2.56).”
HumansMutually adjusted metal model in adults in Mexicohair3 yearsn = 2,120
Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
Five-year cancer risk ranged from 0.18% in the lowest urine-score group to 32% in the highest.Five-year cancer risk ranged from 0.18% in the lowest urine-score group to 32% in the highest.
Compared with blood sugar marker levels of 5.0–6.9%, levels below 5.0% had an adjusted cancer hazard ratio of 1.28, a measure of relative risk.Compared with blood sugar marker levels of 5.0–6.9%, levels below 5.0% had an adjusted cancer hazard ratio of 1.28, a measure of relative risk.